Although the white male predominance may limit generalizability to females and other ethnic groups, obesity and type 2 diabetes are very common comorbidities in our clinic population; thus, overall, this study is supportive for the efficacy and safety of spironolactone in TRH. This evidence concerns the gene TRH and obesity disorder.